ES8305827A1 - "un procedimiento de obtencion de poliosidos capsulares inmunogenos". - Google Patents

"un procedimiento de obtencion de poliosidos capsulares inmunogenos".

Info

Publication number
ES8305827A1
ES8305827A1 ES514496A ES514496A ES8305827A1 ES 8305827 A1 ES8305827 A1 ES 8305827A1 ES 514496 A ES514496 A ES 514496A ES 514496 A ES514496 A ES 514496A ES 8305827 A1 ES8305827 A1 ES 8305827A1
Authority
ES
Spain
Prior art keywords
capsular
polyosides
bacteriae
give
retained material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES514496A
Other languages
English (en)
Spanish (es)
Other versions
ES514496A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BERRI BALZAC
Original Assignee
BERRI BALZAC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERRI BALZAC filed Critical BERRI BALZAC
Publication of ES514496A0 publication Critical patent/ES514496A0/es
Publication of ES8305827A1 publication Critical patent/ES8305827A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES514496A 1981-07-30 1982-07-29 "un procedimiento de obtencion de poliosidos capsulares inmunogenos". Expired ES8305827A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (fr) 1981-07-30 1981-07-30 Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins

Publications (2)

Publication Number Publication Date
ES514496A0 ES514496A0 (es) 1983-04-16
ES8305827A1 true ES8305827A1 (es) 1983-04-16

Family

ID=9261011

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514496A Expired ES8305827A1 (es) 1981-07-30 1982-07-29 "un procedimiento de obtencion de poliosidos capsulares inmunogenos".

Country Status (11)

Country Link
EP (1) EP0071515B1 (enExample)
AT (1) ATE16244T1 (enExample)
CA (1) CA1206905A (enExample)
DD (1) DD202623A5 (enExample)
DE (1) DE3267160D1 (enExample)
DK (1) DK327182A (enExample)
ES (1) ES8305827A1 (enExample)
FR (1) FR2510606A1 (enExample)
IE (1) IE53582B1 (enExample)
NO (1) NO159394C (enExample)
PT (1) PT75301B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0238739B1 (en) * 1986-03-27 1992-02-05 Swiss Serum and Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
KR20080081978A (ko) * 2000-03-16 2008-09-10 더 칠드런스 호스피탈 오브 필라델피아 폐렴구균의 캡슐 다당류 생산의 조절 방법
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
US8398985B2 (en) 2007-04-23 2013-03-19 Serum Institute Of India Ltd. Antigenic polysaccharides and process for their preparation
WO2011148382A1 (en) 2010-05-28 2011-12-01 Biological E Limited An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR20190103256A (ko) 2016-12-30 2019-09-04 수트로박스, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
JP2025531339A (ja) 2022-09-19 2025-09-19 バイオロジカル イー リミテッド 莢膜ポリサッカライドの精製法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166963A (en) * 1936-11-19 1939-07-25 Sharp & Dohme Inc Antigenic polysaccharide complex
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine

Also Published As

Publication number Publication date
EP0071515B1 (fr) 1985-10-30
FR2510606B1 (enExample) 1984-10-26
NO159394B (no) 1988-09-12
DK327182A (da) 1983-01-31
ATE16244T1 (de) 1985-11-15
PT75301A (fr) 1982-08-01
FR2510606A1 (fr) 1983-02-04
IE53582B1 (en) 1988-12-21
NO159394C (no) 1988-12-21
DE3267160D1 (en) 1985-12-05
EP0071515A1 (fr) 1983-02-09
PT75301B (fr) 1984-07-31
NO822592L (no) 1983-01-31
DD202623A5 (de) 1983-09-28
ES514496A0 (es) 1983-04-16
CA1206905A (en) 1986-07-02
IE821705L (en) 1983-01-30

Similar Documents

Publication Publication Date Title
ES8305827A1 (es) "un procedimiento de obtencion de poliosidos capsulares inmunogenos".
DE3784860D1 (de) Verbessertes verfahren zur transformation von pflanzlichen protoplasten.
NO875319D0 (no) Fremgangsmaate for ekstracellulaer fremstilling av homopolysakkarider.
DE69109886D1 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
FR2545099B1 (fr) Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire
JPS5739798A (en) Prepartion of deacetylcephalosporin c or its salt and acetyl esterase used for it
US4169761A (en) Process for the cultivation of viruses
DE3065316D1 (en) Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process
ATE9100T1 (de) Trichosporon kashiwayama ifo 1964, kulturbruehe, zell-freie sterile fluessigkeit, steriles filtrat, steriler ueberstand, steriles konzentrat und steriles trockenprodukt einer kulturbruehe, verfahren zur herstellung einer kulturbruehe, pharmazeutische zusammensetzung, kosmetische zusammensetzung.
JPS57144986A (en) Preparation of lipid having high content of gamma-linolenic acid
EP0391345A3 (en) Method for preparing optically active substances
ATE21033T1 (de) Verfahren zur herstellung eines immunogens aus pasteurella multocida.
WO1990010058A3 (en) Method for production and purification of hepatitis b vaccine
JPS5658491A (en) Immunoactivating substance ies-1638 having antitumor activity, and its preparation
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
EP0337625A3 (en) Probes
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
JPS5554898A (en) Preparation of 3-o-demethyl-fortimicin a
JPS5786295A (en) Preparation of l-glutamic acid by fermentation method
JPS55165799A (en) Preparation of hopan-22-ol and hopene-b
JPS5519070A (en) Preparation of benikoji pigment
JPS55102389A (en) Novel microorganism
JPS54154713A (en) Derivative of glucosamine
RU94025893A (ru) Способ выделения биологически активных веществ

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20011110